What's Happening?
Queue, a startup based in the Bay Area, has announced the launch of its fully autonomous robotic pharmacy kiosks, backed by $12.6 million in seed funding. The funding round was led by AlleyCorp, with additional investments from Riot Ventures, House Capital,
Ubiquity Ventures, Grep Ventures, and Banter Capital. Queue's system automates the prescription fulfillment process, taking sealed wholesale pill bottles and producing filled, verified prescription vials without the need for an on-site pharmacist. The kiosks support 250 of the most prescribed medications in the U.S. and aim to deliver medications at significantly lower costs than traditional pharmacy operations.
Why It's Important?
Queue's autonomous pharmacy kiosks represent a significant advancement in healthcare technology, addressing critical issues such as workforce shortages and economic pressures in the pharmacy industry. By reducing the need for on-site pharmacists, these kiosks could alleviate the burden on existing pharmacy staff and improve access to medications in underserved areas. The technology also promises to enhance accuracy and efficiency in prescription fulfillment, potentially transforming the pharmacy landscape and setting a precedent for further automation in healthcare services.
What's Next?
With the new funding, Queue plans to accelerate product development, expand its deployments with enterprise pharmacy customers, and grow its engineering team. The company has already secured a major national pharmacy chain as a customer and is working on scaling its operations. As the kiosks are deployed in various settings, Queue will gather data to refine its technology and expand its reach. The success of this initiative could lead to broader adoption of similar technologies across the healthcare industry, potentially reshaping how pharmacy services are delivered.
